Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

Biopearl,

Just picked this up on Biopharma Chatter

"$MNTA: Wall Street analysts expect MNTA to grow earnings per share by 86.90% annually this year and 512.00% next year, based on the averages of all analyst estimates. For the next five years, analysts forecast N/A annual EPS growth for MNTA. In the past five years, MNTA's annual EPS growth was 0.00%. MNTA's price/earnings (P/E) ratio is -69.72, and its price/earnings to growth (PEG) ratio is N/A."

Hope they are right! We will be well on our way.

Boing X 2